ONCOLife Articles
PSMA PET/CT May Transform Prostate Cancer Diagnosis and Reduce Biopsies by 50%
ONCOLife | 13 March 2026
Breast Cancer Patients Choosing Alternative Medicine Face Four Times Higher Mortality
ONCOLife | 9 March 2026
Gut Bacteria Decide Whether Nutrients Feed Tumors or Fuel Immunity
ONCOLife | 13 February 2026
Amivantamab Plus Chemotherapy Shows Promising Responses in Colorectal Cancer
Clinical Trials | 11 January 2026
Rewiring RNA: Antisense RNA Therapy Exposes a New Weakness in Pancreatic Cancer
ONCOLife | 8 January 2026
TRBC2-Specific ADC Shows Robust Efficacy in T-Cell Lymphomas and Leukemias
Clinical Trials | 24 December 2025
Engineered Oncolytic Virus Reprograms Immunity and Extends Survival in Brain Cancer
ONCOLife | 20 December 2025
FDA Approves First Subcutaneous Amivantamab Plus Lazertinib for EGFR+ Lung Cancer
FDA & EMA | 18 December 2025
Teclistamab plus Daratumumab Achieves an 83% Risk Reduction in R/R Multiple Myeloma
Clinical Trials
10 December 2025
FDA Approves AKEEGA for BRCA2+ Prostate Cancer as the First Precision Therapy
FDA & EMA
12 December 2025
Ribociclib Maintains Long-Term Disease Control in HR+ HER2 Metastatic Breast Cancer
Clinical Trials
9 December 2025
Preoperative Radiation May Improve Immune Response in HR+ HER2- Breast Cancer
Clinical Trials
11 December 2025
Tucatinib Combination Cuts Progression Risk by 36% in HER2+ Metastatic Breast Cancer
Clinical Trials
10 December 2025
Giredestrant Cuts Risk of Invasive Recurrence by 30% in Early ER+ Breast Cancer
Clinical Trials
10 December 2025
Lunsumio Combo Deliver High Response Rates in Follicular and Large B-Cell Lymphomas
ONCOLife
8 December 2025
Lung Organoids Offer a Revolutionary Path to Transform Drug Testing and Cancer Therapies
Biotech
2 December 2025
Nanotherapy Reprograms Glioblastoma Immunity Through Nose-to-Brain Delivery
ONCOLife
2 December 2025
Enozertinib Shows Strong Systemic and CNS Activity in EGFR Exon 20+ NSC Lung Cancer
Clinical Trials
6 December 2025
Colibactin’s Molecular Blueprint Exposes How a Gut Microbial Toxin Triggers Colorectal Cancer
ONCOLife
6 December 2025
Blood-Based cfDNA Test Demonstrates Potential for Detecting Lung Cancer in Nonsmokers
ONCOLife
5 December 2025
ONCOLife as a cutting-edge oncology magazine designed for oncologists and health professionals. It has flexible format, available both in print and online formats in the US and EU, ONCOLife is dedicated to covering key developments in the field of oncology. We delve into the stories behind significant clinical research and drug developments, highlight the latest news, and offer exclusive interviews.
